KeyGene and GENALICE collaborate in speeding up plant DNA analysis

Date:10-30-2013

KeyGene and GENALICE recently announced that they have entered into a strategic partnership. KeyGene purchased a license of GENALICE MAP, a groundbreaking new sequence-mapping tool to accelerate and improve DNA research.

KeyGene is an Agro-industrial Biotech company focusing on genomic research and technology development to accelerate crop improvement. Using cutting edge molecular genetic technologies, such as next-generation sequencing, KeyGene has a leading and innovative role in this market. “The breakthrough software of GENALICE MAP is a leap forward in improving our analysis pipeline and in staying ahead of competition. We tested, validated and now implemented MAP, as it immediately offers us major competitive advantages on speed and accuracy in DNA analysis. In addition, the strategic partnership with GENALICE allows us to influence new functionalities within the product that will benefit our business,” comments Arjen van Tunen, CEO of KeyGene.

GENALICE is a young and innovative Dutch software company. In a worldwide online launching event it will present its first product to all DNA researchers in the world on 12/12 later this year. “This first commercial deal, even before the official launch of our product, shows the quality of our product and the need for GENALICE MAP in the field of DNA data processing.” says Hans Karten, CTO of GENALICE.

Jos Lunenberg, CEO of GENALICE, further comments: “We are extremely pleased with the partnership with KeyGene. It clearly shows that GENALICE MAP is highly welcomed in the field of plant genomics. Plant DNA is often far more complex than human DNA. This demonstrates that we are also well positioned to deal with complex variations in DNA, which is found in complex diseases such as cancer.”